Beyond the diagnosis of drug-resistant Tuberculosis in Norway: patients' experiences before, during and after treatment
- PMID: 38971760
- PMCID: PMC11227233
- DOI: 10.1186/s12889-024-19342-8
Beyond the diagnosis of drug-resistant Tuberculosis in Norway: patients' experiences before, during and after treatment
Abstract
Background: This study aims to explore the varied experiences of patients with drug-resistant tuberculosis in Norway. The study emphasizes challenges and implications of being diagnosed with drug-resistant tuberculosis, including the impact on psychosocial health during the diagnosis, disease, treatment, isolation and recovery phases. Norway is a low endemic country of tuberculosis. Most patients are immigrants, and some of them have recently arrived in the country. Patients undergoing treatment for drug-resistant tuberculosis endure prolonged and demanding treatment that could affect their psychosocial health.
Methods: This qualitative study conducted 16 in-depth interviews with individuals aged 18 years and above who were diagnosed with drug-resistant tuberculosis. All participants completed the treatment between 2008 and 2020. Fourteen participants were immigrants, and eight of them had resided in Norway for less than four years before diagnosis. Data analysis followed the six-phase reflexive thematic analysis framework, focusing on identifying patterns in participants' experiences, thoughts, expectations and attitudes.
Results: The narratives of the participants highlighted the complexities of navigating the diagnosis of drug-resistant tuberculosis, treatment, side effects and life after treatment. Immigrants encountered additional challenges, including language barriers and adapting to new social environments. All participants reported experiencing physical health issues that additionally affected their mental health and social activity. Several participants had a delayed or prolonged diagnosis that complicated their disease trajectory. Participants with suspected or confirmed contagious pulmonary tuberculosis underwent hospital isolation for periods ranging from weeks to six months. The participants reported mental health issues, social isolation and stigma, however few were offered follow-up by a psychologist. Many participants had persistent problems at the time of the interviews. Three main themes emerged from the analysis: Delayed and prolonged diagnosis; Psychosocial impact of isolation during treatment; The life after tuberculosis.
Conclusion: This study highlights the enduring impact of drug-resistant tuberculosis on patients and the significance of timely diagnosis, psychosocial support and post-treatment follow-up. The participants universally faced serious implications of the disease, including stigma and isolation. Participants who experienced delayed diagnosis, reflected on missed early intervention opportunities. We recommend further research in low endemic countries to evaluate the international and local recommendations on psychosocial support.
Keywords: Drug-resistant tuberculosis; Low-endemic countries; Patients’ experiences; Psychosocial health; Qualitative research.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Similar articles
-
A qualitative study on the experiences of southern European immigrant parents navigating the Norwegian healthcare system.Int J Equity Health. 2021 Jan 21;20(1):42. doi: 10.1186/s12939-021-01384-8. Int J Equity Health. 2021. PMID: 33478515 Free PMC article.
-
Navigating DR-TB Treatment care: a qualitative exploration of barriers and facilitators to retention in care among people with history of early disengagement from drug-resistant tuberculosis treatment in Johannesburg, South Africa.BMC Health Serv Res. 2025 Jan 22;25(1):122. doi: 10.1186/s12913-025-12265-z. BMC Health Serv Res. 2025. PMID: 39844137 Free PMC article.
-
'They prefer hidden treatment': anti-tuberculosis drug-taking practices and drug regulation in Karakalpakstan.Int J Tuberc Lung Dis. 2016 Aug;20(8):1084-90. doi: 10.5588/ijtld.15.0815. Int J Tuberc Lung Dis. 2016. PMID: 27393544
-
Linezolid for drug-resistant pulmonary tuberculosis.Cochrane Database Syst Rev. 2019 Mar 20;3(3):CD012836. doi: 10.1002/14651858.CD012836.pub2. Cochrane Database Syst Rev. 2019. PMID: 30893466 Free PMC article.
-
Community views on active case finding for tuberculosis in low- and middle-income countries: a qualitative evidence synthesis.Cochrane Database Syst Rev. 2024 Mar 21;3(3):CD014756. doi: 10.1002/14651858.CD014756.pub2. Cochrane Database Syst Rev. 2024. PMID: 38511668 Free PMC article. Review.
References
-
- World Health Organization. Global tuberculosis report 2023 Geneva: World Health Organization,; 2023 [updated 2024.02.07. Available from: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/globa....
-
- World Health Organization. WHO operational handbook on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment, 2022 update Geneva: World Health Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO; 2022 [updated 2024.02.07. Available from: https://www.tbonline.info/media/uploads/documents/9789240065116-eng.pdf.
-
- Folkehelseinstituttet. Tuberkuloseveilederen (The Norwegian Tuberculosis Guidelines). Oslo: Folkehelseinstituttet; [updated 2024.02.07. Available from: https://www.fhi.no/nettpub/tuberkuloseveilederen/.
-
- Nordstrand K, Arnesen T, Mengshoel A, Strand Å, Ingebrigtsen T, Heldal E, Stecher M. Årsrapport 2023 Tuberkulose i Norge 2022 - med behandlingsresultater for 2021 (Annual report 2023 Tuberculosis in Norway 2022 - with treatment results for 2021). Oslo, Norway: Folkehelseinstituttet; 2023 [updated 2024.02.07. Available from: https://www.fhi.no/contentassets/1a18d78701514f199d7bdc19ee14fa3f/arsrap....
-
- World Health Organization. WHO operational handbook on tuberculosis. Module 4: treatment - tuberculosis care and support Geneva: World Health Organization; 2022 [updated 2023.11.30. Available from: https://iris.who.int/bitstream/handle/10665/359147/9789240053519-eng.pdf....
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources